 MONTREAL, March 29, 2021 GLOBE NEWSWIRE -- Theratechnologies Inc. Theratechnologies, or the Company on a consolidated basis TSX: TH NASDAQ: THTX, a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce the addition of two new senior resources to support the growth and development of its commercial and pipeline assets. Effective today, Theratechnologies is pleased to welcome Mr. John Leasure as Global Commercial Officer and Mr. Peter Kowal as Vice President, HIV-U.S. Commercial Operations. 